The Valley Desk

NCT06892288 · Interventional trial

A Study to Assess the Efficacy and Safety of Weekly Doses of GLM101 in Participants With PMM2-CDG

Overall registry status Active not recruiting

Phase 2 · Phase 3

Conditions PMM2-CDG, Phosphomannomutase 2 Deficiency

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov